Annual General Meeting
Approval of all Agenda Items
The Annual General Meeting approved the actions of the Executive Board and the Supervisory Board of Merck KGaA, Darmstadt, Germany for fiscal 2021 and approved all of the resolutions on the agenda, including the proposed dividend of € 1.85 per share, an increase of € 0.45 over the previous year.
-
Webcast of the AGM 2022
On the occasion of our AGM 2022, we recorded a webcast of the statements by the Chairman of the Supervisory Board, Wolfgang Büchele, and the report of the CEO Belén Garijo.
Webcast -
Presence & voting results
Here you will find the presence and voting results.
Read more -
Speech by the CEO
Speech by Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. (Check against delivery).
Read the speech
Documents for the annual general meeting of Merck KGaA, Darmstadt, Germany on 22 April 2022
| Download | ||
|---|---|---|
| Dividend announcement | ||
| Information in accordance with Table 8 of the Regulation (EU) 2018/1212 | ||
| Presence and Voting Results | ||
| Invitation for the Annual General Meeting of Merck KGaA, Darmstadt, Germany on 22 April 2022 | PDF (English) PDF (German) |
|
| Explanation of shareholder rights | PDF (English) PDF (German) |
|
| Information on Data Privacy for Shareholders | ||
| Articles of association of Merck KGaA, Darmstadt, Germany | ||
| Sample of the agenda voting card | ||
| Competence-matrix for Supervisory Board candidates | ||
| Overview of auditor rotation | ||
| Overview GL Compensation | PDF (English) PDF (German) |
|
| Annual report of Merck KGaA, Darmstadt, Germany for the fiscal year 2021 including the consolidated financial statements, combined Management report and Supervisory Board report | ||
| Single entity financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2021 including the combined Management report and Supervisory Board report | ||
| Explanations on the submission of statements | PDF (English) PDF (German) |
|
| Information relating to agenda item 9 (Cancellation of the current authorized capital and the creation of new authorized capital) | ||
| Information in accordance with Section 125 of the German Stock Corporation Act (AktG) in conjunction with the Implementing Regulation (EU) 2018/1212 | PDF (English) PDF (German) |
|
| Speech by Belén Garijo, Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. (Pre-released April 11, 2022. Check against delivery.) |
Related News
View All News-
Press Releases
Annual General Meeting: Approval of all Agenda Items
The Annual General Meeting approved the actions of the Executive Board and the Supervisory Board of Merck KGaA, Darmstadt, Germany, for fiscal 2021 and approved all of the resolutions on the agenda, ...
2022/04/22
This might also interest you
-
Annual Report 2021
Group delivered record growth in fiscal 2021. All three business sectors, first and foremost Life Science, contributed to sales growth.
Read more -
Sustainability Report
We transparently inform our stakeholders about our activities and successes, along with the challenges we face. Every year, we publish a comprehensive report.
Read more